Tacrolimus (FK506) monotherapy provides potent and significant suppression of allogeneic foetal rat pancreatic allograft rejection

Transplant Proc. 1998 Dec;30(8):4073-4. doi: 10.1016/s0041-1345(98)01345-1.

Authors

D F du Toit¹, C Muller, Y Mouton, B Page, J Mattysen, R Lyners, C Woodroof

Affiliation

¹ Department of Anatomy and Histology, Faculty of Medicine, University of Stellenbosch, Tygerberg, South Africa.

PMID: 9865300
DOI: 10.1016/s0041-1345(98)01345-1

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
Fetal Tissue Transplantation / immunology*
Fetal Tissue Transplantation / pathology
Gestational Age
Graft Rejection / prevention & control*
Graft Survival
Immunosuppressive Agents / therapeutic use
Lymphocytes / immunology*
Pancreas Transplantation / immunology*
Pancreas Transplantation / pathology
Rats
Rats, Inbred Strains
Rats, Sprague-Dawley
Tacrolimus / therapeutic use*
Transplantation, Homologous
Transplantation, Isogeneic

Substances

Immunosuppressive Agents
Tacrolimus